Rachel Curtis Gravesen
Director/Board Member presso CESSATECH A/S
Profilo
Rachel Curtis Gravesen is currently a Director at Cessatech A since 2022.
Prior to this, she worked as a Communications Manager at Novo Nordisk A.
From 2011 to 2019, she served as Senior VP-Investor Relations & Communications at Genmab A.
She also worked as Vice President-Investor Relations at Pharmaceutical Development Center.
Ms. Gravesen is a graduate of St. John's College, Cambridge and City University London.
Posizioni attive di Rachel Curtis Gravesen
Società | Posizione | Inizio |
---|---|---|
CESSATECH A/S | Director/Board Member | 17/03/2022 |
Precedenti posizioni note di Rachel Curtis Gravesen
Società | Posizione | Fine |
---|---|---|
GENMAB A/S | Investor Relations Contact | 11/03/2019 |
NOVO NORDISK A/S | Public Communications Contact | - |
Pharmaceutical Development Center
Pharmaceutical Development Center Miscellaneous Commercial ServicesCommercial Services Part of AAIPharma, Inc., Pharmaceutical Development Center researches and develops pharmaceutical products. The private company is based in Charlotte, NC. Pharmaceutical Development Center was acquired by AAIPharma, Inc. on July 31, 2001. | Public Communications Contact | - |
Formazione di Rachel Curtis Gravesen
St. John's College, Cambridge | Graduate Degree |
City University London | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 3 |
---|---|
NOVO NORDISK A/S | Health Technology |
GENMAB A/S | Health Technology |
CESSATECH A/S | Health Technology |
Aziende private | 1 |
---|---|
Pharmaceutical Development Center
Pharmaceutical Development Center Miscellaneous Commercial ServicesCommercial Services Part of AAIPharma, Inc., Pharmaceutical Development Center researches and develops pharmaceutical products. The private company is based in Charlotte, NC. Pharmaceutical Development Center was acquired by AAIPharma, Inc. on July 31, 2001. | Commercial Services |
- Borsa valori
- Insiders
- Rachel Curtis Gravesen